|
Canada-0-SCREWS कंपनी निर्देशिकाएँ
|
कंपनी समाचार :
- Emerging treatments for itch in atopic dermatitis: A review
Atopic dermatitis is a chronic inflammatory skin condition with a high prevalence that is increasing The most universal symptom in patients with atopic dermatitis is pruritus; it is often the most troublesome symptom New insights on the mechanism of itch in patients with eczema have been elucidated, involving cross-talk between neural and immune systems, which have advanced our treatments
- Real-world evidence on the benefits of optimal itch relief . . .
Background: In atopic dermatitis (AD), the real-world impact of achieving itch and skin lesion treatment targets compared to partial improvement remains unclear Objective: We assessed the relationship between itch relief (reduction in Worst Itch Numeric Rating Scale [WI-NRS]) and skin clearance (Investigator Global Assessment [IGA] 0 1) with other patient-reported outcomes
- Current Clinical Options for the Management of Itch in Atopic . . .
A systematic review of second-generation antihistamines, such as fexofenadine, cetirizine, or loratadine, did not find any evidence that these agents are effective in improving atopic itch 60 In a trial including 795 children with AD, daily cetirizine was found to be effective in reducing the Scoring of Atopic Dermatitis (SCORAD) score, when
- Atopic Dermatitis Itch: Scratching for an Explanation
Chronic itch is a defining symptom of atopic dermatitis (AD) and leads to significant morbidity The pathophysiology of pruritus in AD involves various mediators and complex neuroimmune interactions Other factors such as disruption of the skin barrier, sweat, and the skin microbiome may also exacerbate itch in these patients
|
|